JP2024509904A5 - - Google Patents

Info

Publication number
JP2024509904A5
JP2024509904A5 JP2023554922A JP2023554922A JP2024509904A5 JP 2024509904 A5 JP2024509904 A5 JP 2024509904A5 JP 2023554922 A JP2023554922 A JP 2023554922A JP 2023554922 A JP2023554922 A JP 2023554922A JP 2024509904 A5 JP2024509904 A5 JP 2024509904A5
Authority
JP
Japan
Prior art keywords
recombinant protein
binder
amino acid
binds
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023554922A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024509904A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/052126 external-priority patent/WO2022190016A1/en
Publication of JP2024509904A publication Critical patent/JP2024509904A/ja
Publication of JP2024509904A5 publication Critical patent/JP2024509904A5/ja
Pending legal-status Critical Current

Links

JP2023554922A 2021-03-09 2022-03-09 新規なDARPinに基づく多重特異性T細胞エンゲージャ Pending JP2024509904A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163158539P 2021-03-09 2021-03-09
US63/158,539 2021-03-09
US202163172973P 2021-04-09 2021-04-09
US63/172,973 2021-04-09
US202163265184P 2021-12-09 2021-12-09
US63/265,184 2021-12-09
PCT/IB2022/052126 WO2022190016A1 (en) 2021-03-09 2022-03-09 Novel darpin based multi-specific t-cell engagers

Publications (2)

Publication Number Publication Date
JP2024509904A JP2024509904A (ja) 2024-03-05
JP2024509904A5 true JP2024509904A5 (cg-RX-API-DMAC7.html) 2025-03-18

Family

ID=81327872

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023554922A Pending JP2024509904A (ja) 2021-03-09 2022-03-09 新規なDARPinに基づく多重特異性T細胞エンゲージャ

Country Status (11)

Country Link
US (2) US11834504B2 (cg-RX-API-DMAC7.html)
EP (1) EP4304731A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024509904A (cg-RX-API-DMAC7.html)
KR (1) KR20230155464A (cg-RX-API-DMAC7.html)
AU (1) AU2022234894A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023018293A2 (cg-RX-API-DMAC7.html)
CA (1) CA3211381A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023012681A2 (cg-RX-API-DMAC7.html)
IL (1) IL305677A (cg-RX-API-DMAC7.html)
MX (1) MX2023010543A (cg-RX-API-DMAC7.html)
WO (1) WO2022190016A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021403658A1 (en) * 2020-12-16 2023-06-29 Molecular Partners Ag Recombinant cd3 binding proteins and their use
WO2022190016A1 (en) * 2021-03-09 2022-09-15 Molecular Partners Ag Novel darpin based multi-specific t-cell engagers
KR20230169182A (ko) * 2021-04-09 2023-12-15 몰리큘라 파트너스 아게 신규한 DARPin 기반 CD70 인게이저
JP2026524079A (ja) * 2023-06-06 2026-07-17 モレキュラー パートナーズ アクチェンゲゼルシャフト 組換えcd2結合タンパク質及びその使用
WO2025163082A1 (en) * 2024-01-31 2025-08-07 Molecular Partners Ag Dll3-specific binding constructs and their use in radiotherapy
WO2025181039A1 (en) 2024-03-01 2025-09-04 Molecular Partners Ag Therapeutic combinations comprising a multi-specific t cell engager

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1332209B1 (en) 2000-09-08 2009-11-11 Universität Zürich Collections of repeat proteins comprising repeat modules
KR20070085314A (ko) 2004-11-12 2007-08-27 바이엘 쉐링 파마 악티엔게젤샤프트 재조합 뉴캐슬 질환 바이러스
KR101268939B1 (ko) 2005-07-08 2013-05-30 유니버시티 오브 취리히 융합 폴리펩티드의 공번역 전좌를 사용한 파아지디스플레이
CA2700391A1 (en) 2007-09-24 2009-04-02 University Of Zuerich Designed armadillo repeat proteins
NZ592591A (en) 2008-11-03 2012-04-27 Molecular Partners Ag Binding proteins comprising ankyrin repeast domains that inhibit the vegf-a receptor interaction
TWI510246B (zh) 2010-04-30 2015-12-01 Molecular Partners Ag 抑制vegf-a受體交互作用的經修飾結合性蛋白質
EP3514169B1 (en) 2010-11-26 2024-03-06 Molecular Partners AG Designed repeat proteins binding to serum albumin
WO2012149439A2 (en) 2011-04-29 2012-11-01 Janssen Biotech, Inc. Il4/il13 binding repeat proteins and uses
SG11201408196RA (en) 2012-06-28 2015-03-30 Molecular Partners Ag Designed ankyrin repeat proteins binding to platelet-derived growth factor
EP2906591A1 (en) 2012-10-15 2015-08-19 Universität Zürich Bispecific her2 ligands for cancer therapy
EP2738180A1 (en) 2012-11-30 2014-06-04 Molecular Partners AG Binding proteins comprising at least two binding domains against HER2.
EP2789630A1 (en) 2013-04-09 2014-10-15 EngMab AG Bispecific antibodies against CD3e and ROR1
US11453708B2 (en) 2013-05-31 2022-09-27 Molecular Partners Ag Designed ankyrin repeat proteins binding to hepatocyte growth factor
EP2839842A1 (en) 2013-08-23 2015-02-25 MacroGenics, Inc. Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof
US9458211B1 (en) 2015-04-02 2016-10-04 Molecular Partners Ag Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains
US20180333296A1 (en) * 2015-09-02 2018-11-22 Dose Medical Corporation Drug delivery implants as intraocular drug depots and methods of using same
US11291721B2 (en) * 2016-03-21 2022-04-05 Marengo Therapeutics, Inc. Multispecific and multifunctional molecules and uses thereof
MY196882A (en) 2016-09-22 2023-05-08 Molecular Partners Ag Recombinant binding proteins and their use
KR20200142525A (ko) 2018-04-05 2020-12-22 노파르티스 아게 암에 대한 삼중특이성 결합 분자 및 이의 용도
TW202010757A (zh) * 2018-04-11 2020-03-16 美商英伊布里克斯公司 具有經受限cd3結合的多重特異性多肽構築體以及相關方法及用途
EP3856245A4 (en) * 2018-09-24 2022-10-26 EyePoint Pharmaceuticals, Inc. MULTISPECIFIC ANTIBODIES AGAINST HPTP - BETA (VE-PTP) AND VEGF
KR20220016944A (ko) 2019-06-04 2022-02-10 몰리큘라 파트너스 아게 개선된 안정성을 갖는 설계된 안키린 반복 도메인
CA3139164A1 (en) 2019-06-04 2020-12-10 Molecular Partners Ag Recombinant fap binding proteins and their use
EP3980452A1 (en) 2019-06-04 2022-04-13 Molecular Partners AG Recombinant 4-1bb binding proteins and their use
JP2022535564A (ja) 2019-06-04 2022-08-09 モレキュラー パートナーズ アクチェンゲゼルシャフト 多選択性タンパク質
AU2020402581A1 (en) 2019-12-11 2022-06-23 Molecular Partners Ag Designed ankyrin repeat domains with altered surface residues
CN114945584A (zh) 2019-12-11 2022-08-26 分子合作伙伴股份公司 重组肽-mhc复合物结合蛋白及其生成和用途
MX2022013945A (es) 2020-05-06 2023-02-14 Molecular Partners Ag Nuevas proteinas de union a repeticiones de anquirina y sus usos.
AU2021271131A1 (en) 2020-05-14 2022-12-15 Molecular Partners Ag Recombinant CD40 binding proteins and their use
IL298168A (en) 2020-05-14 2023-01-01 Molecular Partners Ag Multispecific proteins
US20240108746A1 (en) 2020-12-16 2024-04-04 Molecular Partners Ag Novel slow-release prodrugs
AU2021403658A1 (en) 2020-12-16 2023-06-29 Molecular Partners Ag Recombinant cd3 binding proteins and their use
CA3211368A1 (en) 2021-03-09 2022-09-15 Molecular Partners Ag Novel darpin based cd123 engagers
US20240317852A1 (en) 2021-03-09 2024-09-26 Molecular Partners Ag Novel darpin based cd33 engagers
WO2022190016A1 (en) * 2021-03-09 2022-09-15 Molecular Partners Ag Novel darpin based multi-specific t-cell engagers
EP4305063A1 (en) 2021-03-09 2024-01-17 Molecular Partners AG Protease cleavable prodrugs
KR20230169182A (ko) 2021-04-09 2023-12-15 몰리큘라 파트너스 아게 신규한 DARPin 기반 CD70 인게이저

Similar Documents

Publication Publication Date Title
JP2024099850A5 (cg-RX-API-DMAC7.html)
JP2024508969A5 (cg-RX-API-DMAC7.html)
JP2022511390A5 (cg-RX-API-DMAC7.html)
JP2023123649A5 (cg-RX-API-DMAC7.html)
JP2020114210A5 (cg-RX-API-DMAC7.html)
JP2019511201A5 (cg-RX-API-DMAC7.html)
JP2020530285A5 (cg-RX-API-DMAC7.html)
JP2019531093A5 (cg-RX-API-DMAC7.html)
RU2015144098A (ru) Четырехвалентные биспецифические антитела
JP2021502810A5 (cg-RX-API-DMAC7.html)
JP2023504914A5 (cg-RX-API-DMAC7.html)
JP2023553697A5 (cg-RX-API-DMAC7.html)
JP2021505156A5 (cg-RX-API-DMAC7.html)
JP2020505034A5 (cg-RX-API-DMAC7.html)
CN115057936A (zh) 异源二聚体多特异性抗体形式
WO2021092075A1 (en) IL-2RβγC BINDING COMPOUNDS
JP2013529070A5 (cg-RX-API-DMAC7.html)
JP2022527151A5 (cg-RX-API-DMAC7.html)
JP2014502149A5 (cg-RX-API-DMAC7.html)
JP2014528714A5 (cg-RX-API-DMAC7.html)
RU2014120536A (ru) Белки специфического связывания и их применения
JP2024501771A5 (cg-RX-API-DMAC7.html)
JP2024517871A5 (cg-RX-API-DMAC7.html)
JP2015520172A5 (cg-RX-API-DMAC7.html)
JP2024513559A5 (cg-RX-API-DMAC7.html)